Ajanta Pharma Q1 profit up 29% at ₹148 crore

PTI New Delhi | Updated on July 30, 2020 Published on July 30, 2020

Ajanta Pharma on Thursday reported 28.90 per cent rise in consolidated net profit to ₹147.76 crore for the quarter ended June 30 mainly on account of robust exports.

The company had posted a net profit of ₹114.63 crore for the year-ago same period, the drug firm said in a filing to BSE.

Revenue from operations surged to ₹668.20 crore during the quarter under review from ₹611.94 crore in the same period of 2019-20, it added.

Total export sales in the quarter were at ₹483 crore as against ₹404 crore in the year-ago period, registering a growth of 19 per cent, the company said.

Shares of Ajanta Pharma settled at ₹1,512.15 apiece, up 1.52 per cent from the previous close on BSE.

Follow us on Telegram, Facebook, Twitter, Instagram, YouTube and Linkedin. You can also download our Android App or IOS App.

Published on July 30, 2020
  1. Comments will be moderated by The Hindu Business Line editorial team.
  2. Comments that are abusive, personal, incendiary or irrelevant cannot be published.
  3. Please write complete sentences. Do not type comments in all capital letters, or in all lower case letters, or using abbreviated text. (example: u cannot substitute for you, d is not 'the', n is not 'and').
  4. We may remove hyperlinks within comments.
  5. Please use a genuine email ID and provide your name, to avoid rejection.